Phosphatidylethanol as an objective measure of heavy drinking days in a clinical trial for alcohol use disorder.

Key Points

• PEth serves as an objective measure of heavy drinking days, enhancing accuracy in clinical assessments.
• Findings indicate significant promise for PEth in monitoring alcohol consumption patterns in individuals.
• Assessment involved the use of phosphatidylethanol levels to gauge drinking days versus self-reports, showing distinct advantages.
• Validating these findings in larger cohorts calls for further investigation to ensure reliability across diverse populations.

Abstract